Test Price
2,800 AED✅ Home Collection Available
RPL10 Gene (Autism Susceptibility, X‑Linked Intellectual Disability Type 5) Genetic Test in UAE – 2,800 AED
Executive Summary & Core Metrics
Diagnostic Sensitivity: 99.9% via ISO‑certified processing. Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM. Clinical Guidance: Post‑test telephonic interpretation by a Consultant Medical Geneticist. Insurance: Coverage verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This targeted Next‑Generation Sequencing (NGS) test analyzes the RPL10 gene for pathogenic variants associated with X‑linked autism spectrum disorder and intellectual disability type 5. It provides definitive molecular diagnosis for affected males and carrier status for females, with Sanger confirmation of all reported variants.
| Feature | Our RPL10 NGS Test | Closest Alternative (Whole Exome Sequencing) |
|---|---|---|
| Precision | 100% coverage of RPL10 coding regions with >500× depth | Variable coverage; may miss deep intronic variants |
| Methodology | Targeted NGS with Sanger confirmation | Broad capture NGS, often without targeted validation |
| Turnaround Time | 3–4 Weeks | 6–12 Weeks |
| Cost (AED) | 2,800 | 4,500–6,000 |
Physician Insight & Safety Protocols
“Families navigating developmental delays often carry immense uncertainty. This test provides critical molecular evidence, but results must be correlated with clinical presentation and interpreted by a genetic specialist. A negative result does not exclude other genetic or environmental contributors.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Advisory
Do not discontinue any prescribed therapies or medications without consulting your physician. This genetic test is a diagnostic aid, not a substitute for ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Not indicated for individuals without clinical suspicion of X‑linked inheritance or a positive family history.
- Prenatal testing requires mandatory genetic counselling and informed consent per UAE Medical Liability Law (Federal Decree‑Law No. 4 of 2016).
- Urgent Red Flags: acute seizure episodes, sudden developmental regression, self‑harm, or severe behavioural outbursts require immediate emergency medical evaluation (call 998).
- This test is not a substitute for emergency psychiatric or neurological care.
Patient FAQ & Clinical Guidance
1. What does a positive RPL10 variant mean for my child’s future?
A positive result confirms a genetic variant linked to X‑linked autism spectrum disorder and intellectual disability. This enables personalized therapies, early intervention planning, and informed family counselling.
2. How is the sample collected and can it be done at home?
Sample collection is via a simple blood draw or buccal swab. Our DHA‑licensed VIP mobile phlebotomists perform home visits with temperature‑controlled cold‑chain logistics, daily from 8 AM to 11 PM.
3. Will my insurance cover this test and how long for results?
Many UAE health insurance plans cover genetic testing after pre‑authorisation. Contact us via WhatsApp for verification prior to collection. Results are delivered within 3–4 weeks.
4. What is the methodology used for this test?
Targeted Next‑Generation Sequencing (NGS) covering all coding exons and flanking regions of RPL10, followed by Sanger sequencing verification of all detected variants.
UAE Regulatory & Data Privacy Adherence
Compliance Framework: DNA Labs UAE operates under DHA Facility License No. 1143 and adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 on the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access‑restricted, and processed solely for diagnostic purposes. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | RPL10 Gene (Autism Susceptibility, X‑Linked Intellectual Disability Type 5) Sequencing |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or buccal swab |
| Methodology Used | Targeted Next‑Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | F84.0 (Autistic disorder), F70 (Mild intellectual disability) |
| LOINC Code | 100215-2 (RPL10 gene targeted mutation analysis) |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians